Emergency license at Johnson & Johnson vaccine (J&J) against COVID-19 was given by the competent health service in Mexico COFEPRIS, as announced by the Deputy Minister of Health Hugo Lopez Gatel.
“This authorization for urgent use confirms that the vaccine has the conditions of quality, safety and efficacy, which are necessary for its use,” COFEPRIS said in a separate statement, as broadcast by AMPE.
Earlier yesterday Mexico reported more than 3,000 new cases of infection from COVID-19.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
